| Product NDC: | 0006-0031 |
| Proprietary Name: | FOSAMAX |
| Non Proprietary Name: | alendronate sodium |
| Active Ingredient(s): | 70 mg/1 & nbsp; alendronate sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0006-0031 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020560 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950929 |
| Package NDC: | 0006-0031-44 |
| Package Description: | 4 TABLET in 1 BLISTER PACK (0006-0031-44) |
| NDC Code | 0006-0031-44 |
| Proprietary Name | FOSAMAX |
| Package Description | 4 TABLET in 1 BLISTER PACK (0006-0031-44) |
| Product NDC | 0006-0031 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alendronate sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19950929 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | ALENDRONATE SODIUM |
| Strength Number | 70 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |